MedTrace Logo

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

NCT03106766 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-08-30

No results posted yet for this study

Summary

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Acne cream 2X

Twice daily application of facial acne cream 2X after facial cleansing

DRUG

Acne cream 1X

Twice daily application of facial acne cream 1X after facial cleansing

Sponsors & Collaborators

  • Skin Laser & Surgery Specialists

    collaborator OTHER

  • Next Science TM

    lead INDUSTRY

Principal Investigators

  • Matt Myntti, PhD · Next Science

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-27
Primary Completion
2017-08-14
Completion
2017-08-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03106766 on ClinicalTrials.gov